qfx Now, these PACs, my dear reader, are rather like those society parties where everyone chips in for the champagne, except instead of bubbly, they’re funding political candidates and causes. Fairshake, for instance, backed by the likes of Coinbase and Ripple Labs, splashed a whopping $130 million during the 2024 elections to ensure the crypto crowd had a seat at the table. 🥂📈
Bitcoin’s price, after a brief dalliance with the $118,000 zone, descended below the $115,000 and $113,500 support levels, plunging into a short-term bearish chasm. A most dramatic plot twist, one might say. 🕳️
In a move that could only be described as “let’s see how much chaos we can get away with,” Binance revealed it’s expanding Bitcoin Options for everyone-yes, even your cat. Options are these fancy contracts that say, “Hey, I might buy or sell this thing later, but only if I feel like it, and only at a price I set. No big deal!” Think of it as betting on whether the market will go up or down, with a little extra flair-like betting on whether your neighbor’s new haircut will last more than a week. 🧙♂️
The Solana contraption is apparently…shipping. Murakami is selling pixelated flowers. And the Koreans, bless their industrious hearts, are attempting to legislate the utterly legislatable. A comforting routine, wouldn’t you agree?
You see, this little endeavor is part of the CFTC’s “crypto sprint,” a term that brings to mind images of hurried bureaucrats dashing from one office to another while trying not to spill their coffee. This initiative is birthed from the earnest pleas of President Donald Trump’s Working Group on Digital Asset Markets, which loaded up a grocery list of no less than 18 recommendations. Who doesn’t love a good list? 📜
Amidst this festive atmosphere, BCH on-chain metrics whisper a cautionary tale: the whales, those majestic creatures of the crypto sea, seem to be on vacation. According to IntoTheBlock, BCH large transactions (over $100K), which peaked above $900 million in July, have now plunged below $200 million for the first time in 20 days on Sunday, Aug. 3. 🐳🌊
The chart of UNI/USDT looks like a rebellious teenager trying to rebound after a particularly dramatic summer fling near $11.686. After swooning down to the support line at $9.13, the price rallied with a bullishness that almost insulted the previous hopelessness-performance art on a chart, if you will.
It’s a tale as old as time-or at least as old as the internet: crypto companies find a way to do what they want, regardless of what the law says. In this case, we’re talking about the Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act, which, much to everyone’s surprise, actually tried to put a stop to stablecoin issuers giving out interest or yield. But alas, where there’s a will, there’s a loophole.
And what event, you might ask, could possibly be more significant than the whims of the market? Why, the decision of Artelo Biosciences, a clinical-stage pharmaceutical firm, to adopt Solana as part of its corporate treasury. Yes, you read that correctly. In a move that would have made the great Dostoevsky himself scratch his head in wonder, Artelo became the first publicly traded pharmaceutical company to embrace the digital realm of SOL. With a commitment of $9.475 million from an at-the-market private placement, Artelo has set sail into uncharted waters, guided by the beacon of Solana’s promise.
Bitcoin, that unruly satyr of the financial woods, faced the whip of renewed pressure on Friday, marking its third weekly stumble. Prices flirted with $112,000, a support level as fragile as a glass slipper. The result? A billion-dollar liquidation carnival, as risk-off sentiment spread like a plague, infecting both crypto and equities. A weak U.S. jobs report and new tariffs added fuel to the pyre of growth concerns. 🔥💼
